SpectaCell develops a cell analysis platform combining imaging technology and AI analytics to assess cell therapy performance and accelerate the development and manufacturing of immunotherapies.
SpectaCell has raised €6.0M across 1 funding round from 5 investors, most recently a Seed round in Oct 2026. Based in Ghent, Belgium; active in Software. Data as of 9 Oct 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-10-09 | Seed | €6.0M |
| imec.xpand,InnovationQuarter Capital,PMV’s Flanders Future Tech Fund,Qbic,VIB |
| View deal → |
